0001193125-22-007694.txt : 20220112 0001193125-22-007694.hdr.sgml : 20220112 20220112161600 ACCESSION NUMBER: 0001193125-22-007694 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20220112 ITEM INFORMATION: Other Events FILED AS OF DATE: 20220112 DATE AS OF CHANGE: 20220112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Imago BioSciences, Inc. CENTRAL INDEX KEY: 0001623715 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 454915810 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40604 FILM NUMBER: 22526744 BUSINESS ADDRESS: STREET 1: 329 OYSTER POINT BLVD., 3RD FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650 325 5156 MAIL ADDRESS: STREET 1: 329 OYSTER POINT BLVD., 3RD FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 8-K 1 d247889d8k.htm 8-K 8-K
false 0001623715 0001623715 2022-01-12 2022-01-12

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 12, 2022

 

 

IMAGO BIOSCIENCES, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-40604   45-4915810

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification Number)

329 Oyster Point Blvd., 3rd Floor

South San Francisco, California 94080

(Address of principal executive offices, including Zip Code)

Registrant’s telephone number, including area code: (415) 529-5055

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, par value $0.0001 per share   IMGO   The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 

 


ITEM 8.01

Other Events.

2022 Annual Meeting of Stockholders

Imago BioSciences, Inc. (the “Company”) has scheduled its 2022 Annual Meeting of Stockholders (the “2022 Annual Meeting”) for June 1, 2022. The record date, time and location of the 2022 Annual Meeting will be set forth in the proxy statement for the 2022 Annual Meeting (the “Proxy Statement”) to be distributed to shareholders prior to the meeting.

Stockholder Proposals for the 2022 Annual Meeting

Proposals Pursuant to Rule 14a-8.

Pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended, stockholders may present proper proposals for inclusion in the Proxy Statement and for consideration at the 2022 Annual Meeting. To be eligible for inclusion in the Proxy Statement, stockholder proposals submitted pursuant to Rule 14a-8 must be received by the Company’s Secretary at 329 Oyster Point Blvd., 3rd Floor, South San Francisco, California 94080, no later than January 25, 2022, and must otherwise comply with Rule 14a-8. Any proposal received after such date will be considered untimely.

Other Proposals and Nominations

Under the Company’s Amended and Restated Bylaws (the “Bylaws”), in order to nominate a director or bring any other business before the stockholders at the 2022 Annual Meeting, other than pursuant to Rule 14a-8, stockholders must comply with the procedures and timing specifically described in the Bylaws. To be timely, a stockholder’s notice must be delivered to, or mailed and received at, the principal executive offices of the Company not later than March 3, 2022.

A copy of the Bylaws may be obtained free of charge from the Company’s Secretary at 329 Oyster Point Blvd., 3rd Floor, South San Francisco, California 94080. A nomination or proposal that does not comply with the Bylaws will be disregarded. Compliance with the procedures in the Bylaws does not require the Company to include the proposed nominee or proposal in the Proxy Statement.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    IMAGO BIOSCIENCES, INC.
Date: January 12, 2022     By:  

/s/ Hugh Y. Rienhoff, Jr., M.D.

      Hugh Y. Rienhoff, Jr., M.D.
      Chief Executive Officer
EX-101.SCH 2 imgo-20220112.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 imgo-20220112_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period EX-101.PRE 4 imgo-20220112_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.21.4
Document and Entity Information
Jan. 12, 2022
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001623715
Document Type 8-K
Document Period End Date Jan. 12, 2022
Entity Registrant Name IMAGO BIOSCIENCES, INC.
Entity Incorporation State Country Code DE
Entity File Number 001-40604
Entity Tax Identification Number 45-4915810
Entity Address, Address Line One 329 Oyster Point Blvd.
Entity Address, Address Line Two 3rd Floor
Entity Address, City or Town South San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94080
City Area Code (415)
Local Phone Number 529-5055
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, par value $0.0001 per share
Trading Symbol IMGO
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
XML 6 d247889d8k_htm.xml IDEA: XBRL DOCUMENT 0001623715 2022-01-12 2022-01-12 false 0001623715 8-K 2022-01-12 IMAGO BIOSCIENCES, INC. DE 001-40604 45-4915810 329 Oyster Point Blvd. 3rd Floor South San Francisco CA 94080 (415) 529-5055 false false false false Common Stock, par value $0.0001 per share IMGO NASDAQ true false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.4 html 1 118 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d247889d8k.htm imgo-20220112.xsd imgo-20220112_lab.xml imgo-20220112_pre.xml http://xbrl.sec.gov/dei/2020-01-31 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d247889d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d247889d8k.htm" ] }, "labelLink": { "local": [ "imgo-20220112_lab.xml" ] }, "presentationLink": { "local": [ "imgo-20220112_pre.xml" ] }, "schema": { "local": [ "imgo-20220112.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 25, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 118, "memberCustom": 0, "memberStandard": 0, "nsprefix": "imgo", "nsuri": "http://imagobio.com/20220112", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d247889d8k.htm", "contextRef": "duration_2022-01-12_to_2022-01-12", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d247889d8k.htm", "contextRef": "duration_2022-01-12_to_2022-01-12", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://imagobio.com//20220112/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 13 0001193125-22-007694-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-22-007694-xbrl.zip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end